HHS Bioterror Research Oversight Preserved By Commerce Cmte. DHS Plan
Executive Summary
HHS would retain authority over drug research related to bioterrorism under the House Energy & Commerce Committee mark of the "Homeland Security Act" (HR 5005) completed July 11